| Unique ID issued by UMIN | UMIN000061272 |
|---|---|
| Receipt number | R000069605 |
| Scientific Title | Time Course of Exhaled Hydrogen Concentration Following Oral Administration of a Hydrogen-Rich Jelly |
| Date of disclosure of the study information | 2026/04/15 |
| Last modified on | 2026/04/15 15:15:24 |
Time Course of Exhaled Hydrogen Concentration Following Oral Administration of a Hydrogen-Rich Jelly
Time Course of Exhaled Hydrogen Concentration Following Oral Administration of a Hydrogen-Rich Jelly
Time Course of Exhaled Hydrogen Concentration Following Oral Administration of a Hydrogen-Rich Jelly
Time Course of Exhaled Hydrogen Concentration Following Oral Administration of a Hydrogen-Rich Jelly
| Japan |
Healthy
| Adult |
Others
NO
To evaluate the time course of exhaled hydrogen concentration following oral administration of a hydrogen-rich jelly
Others
Evaluation of the time course of exhaled hydrogen concentration following oral administration of a hydrogen-rich jelly
Exploratory
Explanatory
Not applicable
Increase in exhaled hydrogen concentration from baseline during 0-180 min following oral administration of hydrogen-rich jelly
- Cmax and AUC of the increase in exhaled hydrogen concentration from baseline during 0-180 min following oral administration of hydrogen-rich jelly
- Postprandial increase in exhaled hydrogen concentration from baseline during 0-8 h, and its Cmax and AUC
- Association between gut microbiome profiles and exhaled hydrogen and methane concentrations following oral administration of hydrogen-rich jelly
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Treatment
| Food |
At the first test session, participants consume the same standardized commercially available meal, and at the second test session, they consume hydrogen-rich jelly (10 g containing 0.3 mg of hydrogen). Exhaled hydrogen concentration is measured over time after each intake. A 1-week washout period is provided between the two test sessions.
| 20 | years-old | <= |
| 60 | years-old | >= |
Male and Female
Healthy
1) Individuals currently taking medicines and/or dietary supplements
2) Individuals with food allergies
3) Individuals currently participating in another clinical study, or who have participated in another clinical study within the past 3 months
4) Individuals who are pregnant, may be pregnant, or are breastfeeding
5) Individuals judged by the principal investigator or sub-investigator to be ineligible for participation in this study
20
| 1st name | Fumiko |
| Middle name | |
| Last name | Higashikawa |
Hiroshima University Hospital
Medical Center for Translational and Clinical Research
734-8551
Kasumi 1-2-3, Minami-ku, Hiroshima
082-257-1909
fumiko@hiroshima-u.ac.jp
| 1st name | Fumiko |
| Middle name | |
| Last name | Higashikawa |
Hiroshima University Hospital
Medical Center for Translational and Clinical Research
734-8551
Kasumi 1-2-3, Minami-ku, Hiroshima
082-257-1909
healthy-life@hiroshima-u.ac.jp
Hiroshima University
Shinryo Corporation
Profit organization
Ethical Committee for Clinical Research of Hiroshima University
Kasumi 1-2-3 Minami-Ku, Hiroshima
082-257-1947
iryo-sinsa@office.hiroshima-u.ac.jp
NO
広島大学病院(広島県)
| 2026 | Year | 04 | Month | 15 | Day |
Unpublished
Open public recruiting
| 2026 | Year | 04 | Month | 14 | Day |
| 2026 | Year | 04 | Month | 14 | Day |
| 2026 | Year | 04 | Month | 15 | Day |
| 2027 | Year | 05 | Month | 31 | Day |
| 2026 | Year | 04 | Month | 15 | Day |
| 2026 | Year | 04 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069605